Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord. [electronic resource]

By: Contributor(s): Producer: 19950310Description: 275-81 p. digitalISSN:
  • 0090-4295
Subject(s): Online resources: In: Urology vol. 45
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Clinical Trial; Journal Article

There are no comments on this title.

to post a comment.